According to the Justice Department’s complaint, the insurers paid brokers eHealth, GoHealth and SelectQuote hundreds of ...

CVS Health Corp.’s drug-benefits unit negotiated a deal to make Novo Nordisk A/S’s Wegovy more widely available to its ...

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

CVS and Novo Nordisk have struck a deal that will see the drugstore chain offering the Wegovy weight-loss drug to customers ...

Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...

CEO David Joyner highlighted a strong start to 2025, reporting adjusted EPS of $2.25 and adjusted operating income of $4.6 billion. Full-year 2025 adjusted EPS guidance was raised to $6 to $6.20. CVS ...

Shares of CVS Health jumped after the company reported a strong first quarter and agreed to open up access to Novo Nordisk's weight-loss medication at more affordable prices. The stock was up 8.7% at ...

CVS’s stock surges toward a one-year high after profit and revenue beat expectations, amid strength in the pharmacy business, ...

CVS Health ( NYSE: CVS) on Thursday announced plans to discontinue operations in the individual health insurance business, ...

CVS Health said it will significantly expand access to the blockbuster weight loss drug Wegovy for patients covered by its ...